Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fulvia Ceccarelli

Showing results (181-190 of 199) with videos related to

Pageof 20
Sort By:
The New Microbiologica|December 20, 2022
Hepatitis B and C virus infection in patients with Systemic and Cutaneous Lupus ErythematosusAlessandra Lo Presti, Fulvia Ceccarelli, Maria Dorrucci, et al.
Seminars in Arthritis and Rheumatism|March 2, 2021
Comprehensive disease control in systemic lupus erythematosusFulvia Ceccarelli, Giulio Olivieri, Alessio Sortino, et al.
Rheumatology Advances in Practice|August 22, 2019
An observational multicentre study on the efficacy and safety of assisted reproductive technologies in women with rheumatic diseasesRossella Reggia, Laura Andreoli, Houssni Sebbar, et al.
Frontiers in Immunology|June 17, 2022
Autophagy Hijacking in PBMC From COVID-19 Patients Results in LymphopeniaCristiana Barbati, Alessandra Ida Celia, Tania Colasanti, et al.
Clinical Rheumatology|May 8, 2018
Polymyalgia rheumatica and diverticular disease: just two distinct age-related disorders or more? Results from a case-control studyRossana Scrivo, Maria Chiara Gerardi, Iolanda Rutigliano, et al.
Scientific Reports|July 11, 2020
An exploratory cross-sectional study of subclinical vascular damage in patients with polymyalgia rheumaticaRossana Scrivo, Valeria Silvestri, Francesco Ciciarello, et al.
Journal of Autoimmunity|June 1, 2020
Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in seronegative rheumatoid arthritis patientsTania Colasanti, Danilo Sabatinelli, Carmine Mancone, et al.
Clinical and Experimental Rheumatology|January 21, 2026
Application of lupus comprehensive disease control in newly diagnosed systemic lupus erythematosus patients: results from the Italian multicentre Early Lupus Project inception cohortFulvia Ceccarelli, Matteo Piga, Francesca Romana Spinelli, et al.
Cancer Immunology, Immunotherapy : CII|March 3, 2023
Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approachAndrea Botticelli, Alessio Cirillo, Giulia Pomati, et al.
Clinical and Experimental Rheumatology|June 9, 2015
Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre RegistryLuca Iaccarino, Elena Bartoloni, Linda Carli, et al.
Pageof 20

Showing results (181-190 of 199) with videos related to

Sort By:
Pageof 20
The New Microbiologica|December 20, 2022
Hepatitis B and C virus infection in patients with Systemic and Cutaneous Lupus ErythematosusAlessandra Lo Presti, Fulvia Ceccarelli, Maria Dorrucci, et al.
Seminars in Arthritis and Rheumatism|March 2, 2021
Comprehensive disease control in systemic lupus erythematosusFulvia Ceccarelli, Giulio Olivieri, Alessio Sortino, et al.
Rheumatology Advances in Practice|August 22, 2019
An observational multicentre study on the efficacy and safety of assisted reproductive technologies in women with rheumatic diseasesRossella Reggia, Laura Andreoli, Houssni Sebbar, et al.
Frontiers in Immunology|June 17, 2022
Autophagy Hijacking in PBMC From COVID-19 Patients Results in LymphopeniaCristiana Barbati, Alessandra Ida Celia, Tania Colasanti, et al.
Clinical Rheumatology|May 8, 2018
Polymyalgia rheumatica and diverticular disease: just two distinct age-related disorders or more? Results from a case-control studyRossana Scrivo, Maria Chiara Gerardi, Iolanda Rutigliano, et al.
Scientific Reports|July 11, 2020
An exploratory cross-sectional study of subclinical vascular damage in patients with polymyalgia rheumaticaRossana Scrivo, Valeria Silvestri, Francesco Ciciarello, et al.
Journal of Autoimmunity|June 1, 2020
Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in seronegative rheumatoid arthritis patientsTania Colasanti, Danilo Sabatinelli, Carmine Mancone, et al.
Clinical and Experimental Rheumatology|January 21, 2026
Application of lupus comprehensive disease control in newly diagnosed systemic lupus erythematosus patients: results from the Italian multicentre Early Lupus Project inception cohortFulvia Ceccarelli, Matteo Piga, Francesca Romana Spinelli, et al.
Cancer Immunology, Immunotherapy : CII|March 3, 2023
Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approachAndrea Botticelli, Alessio Cirillo, Giulia Pomati, et al.
Clinical and Experimental Rheumatology|June 9, 2015
Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre RegistryLuca Iaccarino, Elena Bartoloni, Linda Carli, et al.
Pageof 20